Multicenter clinical evaluation of Etest meropenem-vaborbactam (bioMérieux) for susceptibility testing of Enterobacterales (Enterobacteriaceae) and Pseudomonas aeruginosa

Authors

Sophonie Jean, Washington University School of Medicine in St. Louis
Sheri Garrett, bioMérieux Inc.
Claire Anglade, bioMérieux SA
Laurence Bridon, bioMérieux SA
Leanne Davies, University Hospital of Wales
Omai B Garner, University of California, Los Angeles
Jennifer Richards, University Hospital of Wales
Meghan Wallace, Washington University School of Medicine in St. Louis
Mandy Wootton, University Hospital of Wales
Carey-Ann D. Burnham, Washington University School of Medicine in St. Louis

Journal

Journal of clinical microbiology

Publication Date

12-23-2019

Volume

58

Issue

1

First Page

e01205-19

Document Type

Open Access Publication

DOI

10.1128/JCM.01205-19

Rights and Permissions

Jean S, Garrett S, Anglade C, Bridon L, Davies L, Garner OB, Richards J, Wallace M, Wootton M, Burnham CA. Multicenter Clinical Evaluation of Etest Meropenem-Vaborbactam (bioMérieux) for Susceptibility Testing of Enterobacterales (Enterobacteriaceae) and Pseudomonas aeruginosa. J Clin Microbiol. 2019 Dec 23;58(1). doi: 10.1128/JCM.01205-19.

Recommended Citation

Jean, Sophonie; Garrett, Sheri; Anglade, Claire; Bridon, Laurence; Davies, Leanne; Garner, Omai B; Richards, Jennifer; Wallace, Meghan; Wootton, Mandy; and Burnham, Carey-Ann D., "Multicenter clinical evaluation of Etest meropenem-vaborbactam (bioMérieux) for susceptibility testing of Enterobacterales (Enterobacteriaceae) and Pseudomonas aeruginosa." Journal of clinical microbiology. 58, 1. e01205-19 (2019).
https://digitalcommons.wustl.edu/open_access_pubs/8721